TACE (transarterial chemoembolization)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TACE (transarterial chemoembolization), covering 2021-09-24 to 2023-02-16. Get the full timeline:
Most recent: Clinical Trial Update: TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC [Phase 2]